Glenmark Investigational Site 103

Berlin 10117

0 studies enrolling now · 1 studies all time

What they study most

HER2 Expressing Solid Tumours

Studies at this site

• Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers — Stopped early